https://apnews.com/019790c439dfd39a11868ede5d55b6e6

WASHINGTON (AP) — Each year the U.S. approves dozens of new uses for cancer drugs based on early signs that they can shrink or slow the spread of tumors.

But how often do those initial results translate into longer, healthier lives for patients?